Frequently Asked Questions about Pulse Biosciences, Inc. (PLSE)

Name: Pulse Biosciences, Inc. (PLSE) Institutional Financial Dataset
Creator: Olyth
License: https://olyth.xyz

Question 1

What does Pulse Biosciences, Inc. (PLSE) do?

Accepted Answer

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue t...

Question 2

Is Pulse Biosciences, Inc. (PLSE) a good stock to buy?

Accepted Answer

Olyth's institutional analysis of PLSE reveals an Altman Z-Score of 52.19 and a Piotroski F-Score of 2/9. These metrics, combined with its 5-year revenue trend ($0.00B most recent), help investors decide if PLSE fits their risk profile.

Question 3

What is the current P/E ratio for PLSE?

Accepted Answer

As of the latest trading session, Pulse Biosciences, Inc. (PLSE) has a trailing P/E ratio of -18.48.

Question 4

Who is the CEO of Pulse Biosciences, Inc.?

Accepted Answer

The current Chief Executive Officer of Pulse Biosciences, Inc. is Paul Arthur LaViolette.

Question 5

What was PLSE's revenue for the last 5 years?

Accepted Answer

According to its latest income statements, Pulse Biosciences, Inc. reported annual revenues of $0.00B (2025), $0.00B (2024), $0.00B (2023), $0.00B (2022), $0.00B (2021) respectively.

Question 6

Does PLSE pay a dividend?

Accepted Answer

Pulse Biosciences, Inc. does not currently pay a dividend to its shareholders.

Question 7

How much debt and cash flow does PLSE have?

Accepted Answer

In its latest reporting period, Pulse Biosciences, Inc. generated $-0.05B in Free Cash Flow against a total debt load of $0.01B.

Question 8

What is the Price-to-Book (P/B) ratio of Pulse Biosciences, Inc.?

Accepted Answer

The Price-to-Book (P/B) ratio for Pulse Biosciences, Inc. (PLSE) is currently 16.68.

Question 9

What is the Price-to-Sales (P/S) ratio of PLSE?

Accepted Answer

Based on trailing twelve-month data, Pulse Biosciences, Inc. (PLSE) trades at a Price-to-Sales (P/S) ratio of 3877.32.

Question 10

What is Pulse Biosciences, Inc.'s Return on Equity (ROE)?

Accepted Answer

Pulse Biosciences, Inc. (PLSE) has a Return on Equity (ROE) of -73.46%, representing its profitability relative to shareholder equity.

Period	Operating CF	SBC	CapEx	Free CF	True FCF
2025-12	-54.1M	21.5M	-315K	-54.4M	-75.9M
2024-12	-36.3M	13.6M	-125K	-36.5M	-50.1M
2023-12	-33M	7.2M	-121K	-33.2M	-40.3M
2022-12	-47M	5.2M	-401K	-47.4M	-52.6M
2021-12	-54.1M	14.6M	-437K	-54.5M	-69.1M

Period	Operating CF	SBC	CapEx	Free CF	True FCF
2025-12	-54.1M	21.5M	-315K	-54.4M	-75.9M
2024-12	-36.3M	13.6M	-125K	-36.5M	-50.1M
2023-12	-33M	7.2M	-121K	-33.2M	-40.3M
2022-12	-47M	5.2M	-401K	-47.4M	-52.6M
2021-12	-54.1M	14.6M	-437K	-54.5M	-69.1M